Inside Angle

From 3M Health Information Systems

Tag: DRGs

DRGs (Diagnosis Related Groups) is a methodology for classifying patients based on the amount and type of hospital resources needed to treat them. Countries use DRGs or similar classification systems to allocate scarce resources, to determine reimbursement and funding and to measure the quality of care provided by hospitals. DRGs link clinical and financial data, and provide an operational means to define case mix (the range and type of patients a hospital treats). Most developed nations have adopted classification systems as the basis of their payment and quality measurement; many of these methodologies, including DRGs, were developed by 3M. The use of DRGs requires diagnosis and procedure coding, both primary businesses of 3M. This is an example of a language that enables communication across all entities involved in the delivery of healthcare.

Gregg PerfettoGregg Perfetto

Blog post

How can data help you manage your outpatient services

June 27, 2022 / By Gregg Perfetto

Do you wonder what keeps CFOs up at night? No, just me? Well, in case you were wondering, here are some questions every CFO asks themselves: How can my facility […]

Blog post

Where we’ve been and where we’re going: A 50-year perspective on health policy

June 25, 2021 / By Megan Carr, Chet Stroyny

I recently had the opportunity to talk with Chet Stroyny, a program manager for Regulatory and Government Affairs at 3M Health Information Systems, about his 50-year career in the health […]

Blog post

Indian health system in pre-DRGs era

June 21, 2021 / By Naveen Sharma, MD

Why is it a pre-diagnoses related group (DRG) era in India? The major public health schemes in India, including PMJAY, face the challenges of cost escalations, value-based service generation, data […]

Blog post

Payment and quality reform for mental health and substance abuse care: The time is now (part 2)

April 21, 2021 / By Dawn Weimar, RN

In my last blog, I discussed mental health and substance abuse (MHSA) payment and quality in the midst of parity initiatives, team-based care and value-based payment. Certainly, adherence to fee-for-service […]

Blog post

Payment and quality reform for mental health and substance abuse care: The time is now

April 19, 2021 / By Dawn Weimar, RN

We have heard the adage: “The definition of insanity is repeating the same mistakes but expecting a different result.”  This adage can be applied to the state of mental health and […]

Blog post

Consequences of the COVID-19 pandemic on the treatment of patients in German hospitals – A first impression

Sept. 3, 2020 / By Raphael Graf, Andre Cools, Daniel Schmithausen

It is undeniably clear that the COVID-19 pandemic has had and continues to have a big impact on us all. In discussions with our customers, they reported that many patients […]

Blog post

Toward a health system reimbursement framework

Feb. 21, 2020 / By Vladimir Lazarevik, MD, MPH

There are many questions healthcare leaders across the Gulf are asking when exploring health system reimbursement options, including “What are the available innovative reimbursement models?”, “How to define successful reforms?” […]

Blog post

Introducing competition and price transparency into the Medicare payment system

Nov. 1, 2017 / By Richard Averill, MS, Richard Fuller, MS

Would an Amazon-like price shopping experience for individual healthcare services help control healthcare costs? Price transparency is frequently cited as a possible strategy for reducing the cost of healthcare because […]

Blog post

Sepsis 3 Consensus definitions—the impact on quality (part two)

June 10, 2016 / By Cheryl Manchenton, RN

In my previous blog, I addressed concerns about the new Sepsis 3 definitions.  In this blog (part 2), I will further flush out implications for specific quality metrics and also […]

Blog post

Controlling the cost of pharmaceuticals through the EAPG payment system

Oct. 16, 2015 / By Norbert Goldfield, MD, Richard Fuller, MS

In a recent blog we made the case for quantifying the net effect of drugs upon health expenditures so as to make more rational decisions. Providing information about costs and […]